Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
Sales | 791 | 2 | 466 | 405 | 0 |
Gross Profit | 791 | 2 | 466 | 405 | N/A |
Operating Expenses | 12,489 | 3,412 | 128 | 168 | 0 |
Operating Income | -11,698 | -3,411 | 338 | 238 | N/A |
Interest Expense | 241 | 298 | 0 | 0 | 0 |
Other Income | -105 | 44 | 0 | 0 | 0 |
Pre-tax Income | -12,044 | -3,665 | 338 | 238 | 0 |
Income Tax | N/A | N/A | 54 | 33 | N/A |
Net Income Continuous | -11,957 | -3,665 | 284 | 205 | N/A |
Net Income | $-11,957 | $-3,665 | $284 | $205 | $N/A |
EPS Basic Total Ops | -8,645.65 | -2,855.86 | 6.01 | 6.01 | N/A |
EPS Basic Continuous Ops | -6,048.39 | -1,965.18 | 7.32 | 5.27 | N/A |
EPS Diluted Total Ops | -8,642.64 | -2,855.86 | 6.01 | 3.00 | N/A |
EPS Diluted Continuous Ops | -6,046.39 | -1,965.18 | 6.12 | 4.47 | N/A |
EBITDA(a) | $-11,605 | $-3,411 | $338 | $238 | $N/A |